22nd Century Group (Nasdaq: XXII) will announce its second

BUFFALO, NY, July 27 Feb. 20, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health through advanced plant technologies with reduced tobacco, hemp/ cannabis and hops, will host a live webcast on Tuesday, August 9, 2022 at 10:00 a.m. ET to discuss its second quarter 2022 results, which will be released in a press release at 6:00 a.m. ET the same day.

During the webcast, James A. Mish, CEO; John Miller, President of Tobacco Products; and Hugh Kinsman, Chief Financial Officer, will review financial results and discuss progress at each of the company’s three franchises.

Following the prepared remarks by management and the presentation of slides, the Company will hold a question and answer session, during which management will accept questions from interested analysts. Investors, shareholders and members of the media will also have the opportunity to ask questions of management by submitting questions via the interactive webcast during the event.

The live and archived webcast, interactive Q&A and slide presentation will be accessible on the Events webpage in the Company’s Investor Relations section of the website at www.xxiicentury.com/investors /events. Please access the website at least 15 minutes before the start of the webcast to register and, if necessary, download and install any required software.

About 22nd Century Group, Inc.
22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on reducing tobacco harm, reducing tobacco nicotine, and improving health and well-being through phytology. Backed by dozens of patents allowing it to control the biosynthesis of nicotine in the tobacco plant, the Company has developed proprietary reduced nicotine (RNC) tobacco plants and cigarettes, which have become the cornerstone of the Full FDA Plan to combat mortality and widespread disease caused by smoking. The company received the first and only MRTP clearance from the FDA for a combustible cigarette in December 2021. In tobacco, hemp/cannabis and hops plants, 22nd Century uses modern plant breeding technologies including genetic engineering , gene editing and molecular breeding to provide solutions for the life science and consumer product industries by creating new proprietary plants with optimized alkaloid and flavonoid profiles along with improved yields and valuable agronomic characteristics.

Learn more about 21st century.comon Twitteron LinkedInand on Youtube.

Caution Regarding Forward-Looking Statements
Except for historical information, all statements, expectations and assumptions in this press release are forward-looking statements. Forward-looking statements generally contain words such as “anticipate”, “believe”, “consider”, “continue”, “could”, “estimate”, “expect”, “explore”, “expect”, “target ‘, ‘advice’, ‘intend’, ‘likely’, ‘may’, ‘plan’, ‘potential’, ‘predict’, ‘preliminary’, ‘probable’, ‘project’, ‘promising’, “seek”, “should”, “steal”, “would” and similar expressions. Actual results may differ materially from those expressed or implied in the forward-looking statements. Important factors that could cause actual results to differ materially are set forth in the “Risk Factors” section of the company’s annual report on Form 10-K and quarterly reports filed on Form 10-Q. All information provided in this release is as of the date hereof, and the Company undertakes no obligation and does not intend to update these forward-looking statements, except as required by law.

Investor Relations and Media Contact:
Joseph T. Schepers
22nd Century Group, Inc.
Vice President Investor Relations and Communications
[email protected]

Darrow Associates Investor Relations
Matt Kreps
Such. : 214-597-8200
[email protected]

Comments are closed.